Rewriting the rules of CMV prevention

<p>In this episode of Denatured, you’ll hear from Ian McGowan, Chief Medical Officer at Synklino and James Hunter, associate professor of transplantation at Oxford University. We explore transplantation and antiviral innovation and why CMV remains one of the most persistent and consequential challenges facing transplant patients today.</p><p></p><p><b>Host</b></p><p><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/jennifersmithparker/" target="_blank">Jennifer C. Smith-Parker</a>, Director of Insights, BioSpace</p><p></p><p><b>Guests</b></p><p><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/ian-mcgowan-3270805/" target="_blank">Ian McGowan</a>, CMO, Synklino</p><p>James Hunter, Associate Professor of Transplantation, Oxford University</p><p></p><p><i>Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.</i></p><h3><b>Custom Fields</b></h3>